Kyntra Bio (KYNB) Times Interest Earned (2014 - 2026)
Kyntra Bio (KYNB) posted Times Interest Earned of -$4.61 for Q1 2026, up 98.98% sequentially from -$450.4 in Q4 2025, and up 7.39% YoY from -$4.29 in Q1 2025.
Kyntra Bio (KYNB) Times Interest Earned (2014 - 2026) Analysis & Trends
Kyntra Bio has reported Times Interest Earned for 13 years, with the latest figure at -$4.61 in Q1 2026.
- Quarterly Times Interest Earned rose 7.39% year-over-year to -$4.61 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$5.52 (up 9.79% YoY) and the FY2025 annual result came in at -$5.24, up 43.54% from the prior year.
- Times Interest Earned improved to -$4.61 in Q1 2026 per KYNB's latest filing, from -$450.4 in the prior quarter.
- Over five years, Times Interest Earned peaked at -$0.7 in Q4 2024 and troughed at -$450.4 in Q4 2025.
- A 5-year average of -$40.62 and a median of -$16.96 in 2024 frame the typical range for Times Interest Earned.
- The sharpest annual moves came in 2022 and 2025: Times Interest Earned soared 99.65% in 2022, then slumped 64167.09% in 2025.
- Over 5 years, Times Interest Earned stood at -$4.36 in 2022, then tumbled by 506.88% to -$26.45 in 2023, then jumped by 97.35% to -$0.7 in 2024, then plunged by 64167.09% to -$450.4 in 2025, then soared by 98.98% to -$4.61 in 2026.
- According to Business Quant data, Times Interest Earned over the past three periods registered -$4.61, -$450.4, and -$2.6 for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Times Interest Earned (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | 117.59 |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | - |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 8.18 |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | 2.82 |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | 76.86 |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | -0.08 |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | 1.42 |
| 10 | Kyntra Bio | 30.42 Mn | 30.42 Mn | 1.47 Mn | -7.42 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -7.42 |
| Mar 31, 2026 | -4.61 |
| Dec 31, 2025 | -450.40 |
| Sep 30, 2025 | -2.60 |
| Jun 30, 2025 | -4.02 |
| Mar 31, 2025 | -4.97 |
| Dec 31, 2024 | -0.70 |
| Sep 30, 2024 | -16.45 |
| Jun 30, 2024 | -16.00 |
| Mar 31, 2024 | -16.96 |
| Dec 31, 2023 | -26.45 |
| Sep 30, 2023 | -21.89 |
| Jun 30, 2023 | -28.69 |
| Mar 31, 2023 | -32.08 |
| Dec 31, 2022 | -4.36 |
| Sep 30, 2022 | -23.09 |
| Jun 30, 2022 | -19.19 |
| Mar 31, 2022 | -18.04 |
| Dec 31, 2021 | -1,229.46 |
| Sep 30, 2021 | 0.42 |